CD79A and nasopharyngeal carcinoma: EBV/IgA/VCA and EBV/IgA/EA antibody titers, especially EBV/IgA/VCA, have been used for the screening and diagnosis of NPC for over 30 years in Southern Chinese populations [7, 9–11].